Clinical Trial Update: ASP (PPI_H2RA) Study-H2RA Versus PPI for the Prevention of Recurrent UGIB in High-risk Users of Low-dose ASA [Phase 3]

View source ↗

Summary

A Phase 3 trial conducted by the Chinese University of Hong Kong compares a histamine H2 receptor antagonist versus a proton pump inhibitor for preventing recur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Gastrointestinal Bleeding

Drugs mentioned

• H2 receptor antagonist
• Proton Pump Inhibitor (proton pump inhibitor)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Upper Gastrointestinal Bleeding | Phase 3 | Status: COMPLETED